Hepatitis C virus mixed genotype infection in patients on haemodialysis

Journal of Viral Hepatitis

Volumn 7, Issue 2, 2000, Pages 153-160

  Qian, K P ^a   Natov, S N ^b   Pereira, B J G ^b   Lau, J Y N ^a,c  

^a Department of Medicine   (United States)

^b TUFTS UNIVERSITY   (United States)

^c Valeant Pharmaceuticals International   (United States)

Author keywords

Genotype; HCV; Infection; Kidney; Quantification; Sensitivity; Transplant

Indexed keywords

HEPATITIS C ANTIBODY; VIRUS RNA;

ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FOLLOW UP; GENOTYPE; HEMODIALYSIS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HYBRIDIZATION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROLOGY;

CLONING, MOLECULAR; CROSS-SECTIONAL STUDIES; DNA, VIRAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LONGITUDINAL STUDIES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RENAL DIALYSIS;

EID: 0034108582     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00208.x     Document Type: Article

References (27)

1. 1 Choo QL, Richman KH, Han JH et al. Genetic organization and diversity of the hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 2451-2455.
2. 2 Ogata N, Alter HJ, Miller RH, Purcell RH. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus. Proc Natl Acad Sci USA 1991; 88: 3391-3396.
3. 3 Okamoto H, Kojima M, Okada S et al. Genetic drift of hepatitis C virus during a 8.2-year infection in a chimpanzee: variability and stability. J Virol 1992; 190: 894-899.
4. 4 Simmonds P. Variability of hepatitis C virus. Hepatology 1995; 21: 570-583.
5. 5 Simmonds P, Alberti A, Bonino F et al. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology. 1994; 19: 1321-1324.
6. 6 Marousis CG, Lau JYN. Genetic heterogeneity of hepatitis C virus and its clinical implications. Dig Dis 1997; 15: 192-206.
7. 7 Davis GL. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 1994; 21: 1-3.
8. 8 Zein NN, Persing DH. Hepatitis C virus genotypes: current trends and future implications. Mayo Clin Proc 1996; 71: 458-462.
9. 9 Ohba K, Mizokami M, Ohno T et al. Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis. Virus Res 1995; 36: 201-214.
10. 10 Nousbaum JB, Pol S, Nalpas B et al. Hepatitis C virus type 1b (II) infection in France and Italy. Ann Intern Med 1995; 122: 161-168.
11. 11 Zein NN, Rakela J, Krawitt EL, Reddy KR, Tominaga T, Persing DH. Hepatitis C virus genotypes in the United States: epidemiology, pathogenicity, and response to interferon therapy. Collaborative study. Ann Intern Med 1996; 125: 634-639.
12. 12 Dusheiko G, Simmonds P. Sequence variability of hepatitis C virus and its clinical relevance. J Viral Hepat 1994; 1: 3-15.
13. 13 Koyoyashi M, Tanaka E, Sodeyama T, Urushihara A, Matsumoto A, Kiyosawa K. The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses. Hepatology 1996; 23: 695-699.
14. 14 Lau JYN, Davis GL, Prescott LE et al. Distribution of hepatitis C virus genotypes in United States patients with chronic hepatitis C seen in tertiary referral centers. Ann Intern Med 1996; 124: 868-876.
15. 15 Darwin C.The Origin of Species. London: Murray Press, 1859.
16. 16 Wright TL, Hollander H, Pu X et al. Hepatitis C in HIV-infected patients with and without AIDS: prevalence and relationship to patient survival. Hepatology 1994; 20: 1152-1155.
17. 17 Simmonds P, Rose KA, Graham S et al. Mapping of serotype-specific, Immunodominant epitopes in the NS-4 region of hepatitis C virus (HCV): use of type-specific peptides to serologically differentiate infections with HCV types 1, 2 and 3. J Clin Microbiol 1993; 31: 1493-1503.
18. 18 McOmish F, Chan SW, Dow BC et al. Detection of three types of hepatitis C virus in blood donors: investigation of type-specific differences in serology reactivity and rate of alanine aminotransferase abnormalities. Transfusion 1993; 33: 7-13.
19. 19 Lau JYN, Mizokami M, Kolberg JA et al. Application of six hepatitis C virus genotyping systems to the sera of patients with chronic hepatitis C in the United States. J Infect Dis 1995; 171: 281-289.
20. 20 Nelson DR, Marousis CG, Davis GL et al. The role of hepatitis C virus-specific cytotoxic T-lymphocytes in chronic hepatitis C. J Immunol 1997; 158: 1473-1481.
21. 21 Collins ML, Zayati C, Detmer JJ et al. Preparation and characterization of RNA standards for use in quantitative branched DNA hybridization assays. Anal Biochem 1995; 226: 120-129.
22. 22 Detmer J, Lagier R, Flynn J et al. Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology. J Clin Microbiol 1996; 34: 901-908.
23. 23 Davidson F, Simmonds P, Ferguson JC et al. Survey of major genotypes and subtypes of hepatitis C virus using RFLP of sequences amplified from the 5′ noncoding region. J Gen Virol 1995; 76: 1197-1204.
24. 24 Stuyver L, Rossau R, Wyseur A et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 1993; 74: 1093-1102.
25. 25 Lau JYN, Simmonds P, Urdea MS. Implications of variations of 'conserved' regions of hepatitis C virus genome, Lancet 1995; 346: 425-426.
26. 26 Lau JYN, Davis GL, Brunson ME et al. Hepatitis C virus infection in renal transplant recipients. Hepatology 1993; 18: 1027-1031.
27. 27 Garcia G, Terrault N, Wright TL. Hepatitis C virus infection in the immunocompromised patient. Semin Gastrointest Dis 1995; 6: 35-45.